Initiation of a phase-I trial of neutron capture therapy at the MIT research reactor
Journal Article
·
· Transactions of the American Nuclear Society
OSTI ID:411518
- Massachussets Institute of Technology, Cambridge, MA (United States); and others
The Massachusetts Institute of Technology (MIT), the New England Medical Center (NEMC), and Boston University Medical Center (BUMC) initiated a phase-1 trial of boron neutron capture therapy (BNCT) on September 6, 1994, at the 5-MW(thermal) MIT research reactor (MITR). A novel form of experimental cancer therapy, BNCT is being developed for certain types of highly malignant brain tumors such as glioblastoma and melanoma. The results of the phase-1 trials on patients with tumors in the legs or feet are described.
- OSTI ID:
- 411518
- Report Number(s):
- CONF-951006--
- Journal Information:
- Transactions of the American Nuclear Society, Journal Name: Transactions of the American Nuclear Society Vol. 73; ISSN 0003-018X; ISSN TANSAO
- Country of Publication:
- United States
- Language:
- English
Similar Records
License amendment for neutron capture therapy at the MIT research reactor
The MIT/NEMC program in neutron capture therapy
Research needs for neutron capture therapy
Conference
·
Thu Dec 31 23:00:00 EST 1992
· Transactions of the American Nuclear Society; (United States)
·
OSTI ID:6911808
The MIT/NEMC program in neutron capture therapy
Conference
·
Tue Dec 31 23:00:00 EST 1991
· Transactions of the American Nuclear Society; (United States)
·
OSTI ID:6953599
Research needs for neutron capture therapy
Conference
·
Thu Nov 30 23:00:00 EST 1995
·
OSTI ID:155260